COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report von Chapagain, Udita, Krigman, Hannah R., Hagemann, Ian S., Weiss, Mia C., Sun, Lulu

Volltext

Systemic Treatment of Soft Tissue Sarcomas in the Geriatric Population von Weiss, Mia C.

Volltext

Truly Man's Best Friend: Canine Cancers Drive Drug Repurposing in Osteosarcoma von Weiss, Mia C, Eulo, Vanessa, Van Tine, Brian A

Volltext

Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma von Van Tine, Brian A, Weiss, Mia C, Hirbe, Angela C, Oppelt, Peter J, Abaricia, Sarah, Trinkaus, Kathryn, Luo, Jingqin, Berry, Shellie, Ruff, Tyler, Callahan, Cheryl, Toensikoetter, Jacqui, Ley, Jessica, Siegel, Marilyn J, Dehdashti, Farrokh, Siegel, Barry A, Adkins, Douglas R

Volltext

Relapsed Synovial Sarcoma: Treatment Options von Weiss, Mia C., Van Tine, Brian A.

Volltext

The clinical utility of next-generation sequencing for bone and soft tissue sarcoma von Gusho, Charles A., Weiss, Mia C., Lee, Linus, Gitelis, Steven, Blank, Alan T., Wang, Dian, Batus, Marta

Volltext

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma von Heater, Natalie K, Okuno, Scott, Robinson, Steven, Attia, Steven, Seetharam, Mahesh, Siontis, Brittany L, Yoon, Janet, Chawla, Sant, Milhem, Mohammed M, Monga, Varun, Skubitz, Keith, Charlson, John, Hirbe, Angela C, Weiss, Mia C, Van Tine, Brian, Agulnik, Mark

Volltext

Clinical benefit of next generation sequencing in soft tissue and bone sarcoma: Rush University Medical Center’s experience von Weiss, Mia C., Blank, Alan, Gitelis, Steven, Fidler, Mary J., Batus, Marta

Volltext

SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma von Dickson, Mark Andrew, Ballman, Karla V., Weiss, Mia C., Attia, Steven, Wagner, Michael J, Pollack, Seth, Choy, Edwin, Wagner, Andrew J., Wilky, Breelyn A., Davis, Lara E., Riedel, Richard F., Tap, William D.

Volltext

A phase II trial with safety lead-in to evaluate the addition of sotigalimab, a CD40 agonistic monoclonal antibody, to standard-of-care doxorubicin for the treatment of advanced sa... von Bose, Sminu (Sam), Ge, Liner, Lee, Shing M, Van Tine, Brian Andrew, Agulnik, Mark, Weiss, Mia C., Lacuna, Kristine Peregrino, Sender, Naomi, Sta Ana, Sarah, Hsu, Frank J., Schwartz, Gary K., Ingham, Matthew

Volltext

A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma von Oza, Jay, Lee, Shing Mirn, Weiss, Mia C., Siontis, Brittany L, Powers, Benjamin C., Chow, Warren Allen, Magana, Wendy, Sheikh, Tahir, Piekarz, Richard, Schwartz, Gary K., Ingham, Matthew

Volltext

Interim phase 1 results for SQ3370 in advanced solid tumors von Chawla, Sant P., Batty, Kathleen, Aleckovic, Masa, Bhadri, Vivek, Bui, Nam, Guminski, Alexander David, Mejia Oneto, Jose Manuel, Srinivasan, Sangeetha, Strauss, James Fredric, Subbiah, Vivek, Weiss, Mia C., Wilson, Rosalind, Yee, Nathan A., Zakharian, Michael, Kwatra, Vineet

Volltext

Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma von Van Tine, Brian Andrew, Eulo, Vanessa, Toeniskoetter, Jacqui, Ruff, Tyler, Luo, Jingqin, Kemp, Lindsey, Moreno Tellez, Cristiam, Weiss, Mia C., Hirbe, Angela C., Meyer, Christian Frederick, Elias, Anthony D., Diamond, Mark, Hartner, Lee P., Bui, Nam, Ganjoo, Kristen N., Maki, Robert G., Wilky, Breelyn A.

Volltext

A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas von Agulnik, Mark, Okuno, Scott H., Van Tine, Brian Andrew, Pollack, Seth, Weiss, Mia C., Hirbe, Angela C., Viveiros, Pedro, Schulte, Brian, Frankel, Paul Henry, Attia, Steven, Siontis, Brittany L., Milhem, Mohammed M., Monga, Varun, Charlson, John A., Robinson, Steven Ian, Yoon, Janet

Volltext

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chond... von Lacuna, Kristine Peregrino, Lee, Shing M, Ge, Liner, Druta, Mihaela, Conley, Anthony Paul, Keohan, Mary Louise, Agulnik, Mark, Burgess, Melissa Amber, Chalmers, Anna Weinberg, D'Amato, Gina Z., Powers, Benjamin, Seetharam, Mahesh, Siontis, Brittany L, Weiss, Mia C., Bose, Sminu (Sam), Sheikh, Tahir, Piekarz, Richard, Schwartz, Gary K., Ingham, Matthew

Volltext

A randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition in metastatic soft tissue sarcoma von Eulo, Vanessa Anne, Wilky, Breelyn A., Luo, Jingqin, Hirbe, Angela C., Weiss, Mia C., Oppelt, Peter John, Abaricia, Sarah, Toeniskoetter, Jacqui, Ruff, Tyler, Maki, Robert G, Van Tine, Brian Andrew

Volltext

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma von Van Tine, Brian Andrew, Hirbe, Angela C., Luo, Jingqin, Oppelt, Peter John, Weiss, Mia C., Eulo, Vanessa Anne, Toeniskoetter, Jacqui, Haarberg, Sasha, Abaricia, Sarah, Ruff, Tyler, Bomalaski, John S., Johnston, Amanda, Kuo, Chih-Ling, Shiu, Chiung-Fang, Ingham, Matthew, Bui, Nam, Chawla, Sant P., Schwartz, Gary K., Ganjoo, Kristen N.

Volltext

A case of Ewing-like sarcoma showing trilaminar differentiation after treatment von Weiss, Mia C., Batus, Marta, Jadhav, Rahul B., Utset, Manuel, O'Donoghue, Cristina, Miller, Ira

Volltext

Abstract B114: A Phase 1/1b study of KAZ954 alone and in combination with spartalizumab (PDR001) and taminadenant (NIR178) in patients with advanced gastrointestinal malignancies von Mahalingam, Devalingam, Lin, Chia-Chi, Bedard, Philippe L., Nicola, Massimo Di, Wainberg, Zev, LoRusso, Patricia, Pant, Shubham, Ma, Brigette B.Y., Yong, Wei-Peng, Weiss, Mia C., Amatu, Alessio, Yamazaki, Kentaro, Nardi, Lisa, Lee, Jong Bong, Roy, Mike, Dang, Anhthu, Yang, Shu, Pereira, Bernard, Otero, Javier A., Macarulla, Teresa

Volltext

Abstract PR008: MYTHIC: First-in-human (FIH) biomarker-driven phase I trial of PKMYT1 inhibitor lunresertib (lunre) alone and with ATR inhibitor camonsertib (cam) in solid tumors w... von Yap, Timothy A, Schram, Alison, Lee, Elizabeth K, Simpkins, Fiona, Weiss, Mia C, LoRusso, Patricia, Højgaard, Martin, Carneiro, Benedito A, Moy, Ryan H, Garrido-Laguna, Ignacio, Koehler, Maria, Unger, Thaddeus J, Bacque, Emeline, Aguado-Fraile, Elia, Sethuraman, Sunantha, Dhake, Snehal, Liu, Yajun, Fretland, Adrian J, Sun, Xizi, Xu, Yi, Hawkey, Nathan, Truong, Jen, Lheureux, Stephanie

Volltext